141 related articles for article (PubMed ID: 38668056)
1. True Donor Cell Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: Diagnostic and Therapeutic Considerations-Brief Report.
Hoffmann M; Banz Y; Halter J; Schoumans J; Tchinda J; Bacher U; Pabst T
Curr Oncol; 2024 Apr; 31(4):2067-2075. PubMed ID: 38668056
[TBL] [Abstract][Full Text] [Related]
2. Donor cell-derived acute promyelocytic leukemia after allogeneic hematopoietic stem cell transplantation.
Bouvier A; Ribourtout B; François S; Orvain C; Paz DL; Beucher A; Guérard A; Guardiola P; Ugo V; Blanchet O; Geneviève F; Schmidt A; Hunault-Berger M
Eur J Haematol; 2018 Oct; 101(4):570-574. PubMed ID: 30007088
[TBL] [Abstract][Full Text] [Related]
3. Donor cell leukemia: a review.
Wiseman DH
Biol Blood Marrow Transplant; 2011 Jun; 17(6):771-89. PubMed ID: 20951819
[TBL] [Abstract][Full Text] [Related]
4. Development of leukemia in donor cells after allogeneic stem cell transplantation--a survey of the European Group for Blood and Marrow Transplantation (EBMT).
Hertenstein B; Hambach L; Bacigalupo A; Schmitz N; McCann S; Slavin S; Gratwohl A; Ferrant A; Elmaagacli A; Schwertfeger R; Locasciulli A; Zander A; Bornhäuser M; Niederwieser D; Ruutu T;
Haematologica; 2005 Jul; 90(7):969-75. PubMed ID: 15996934
[TBL] [Abstract][Full Text] [Related]
5. Transformation of Severe Aplastic Anemia into Donor Cell Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: A Rare Case Report.
Wang Q; Xu H; Yu W; Sun L; Zhao H; Shi X
Am J Case Rep; 2024 Apr; 25():e943801. PubMed ID: 38632857
[TBL] [Abstract][Full Text] [Related]
6. Need for an accurate molecular diagnosis to assess the donor origin of leukemia relapse after allogeneic stem cell transplantation.
Spinelli O; Giussani U; Borleri G; Lazzari M; Michelato A; Dotti G; Barbui T; Rambaldi A
Haematologica; 2000 Nov; 85(11):1153-7. PubMed ID: 11064467
[TBL] [Abstract][Full Text] [Related]
7. Donor cell-derived acute lymphocytic leukemia after allogeneic stem cell transplantation for multiple myeloma.
Igarashi N; Chou T; Hirose T; Imai Y; Ishiguro T; Nemoto K
Int J Hematol; 2009 Oct; 90(3):378-382. PubMed ID: 19693451
[TBL] [Abstract][Full Text] [Related]
8. Synchronous development of acute myeloid leukemia in recipient and donor after allogeneic bone marrow transplantation: report of a case with comments on donor evaluation.
Glasser L; Meloni-Ehrig A; Greaves W; Demel KC; Butera J
Transfusion; 2009 Mar; 49(3):555-62. PubMed ID: 19040490
[TBL] [Abstract][Full Text] [Related]
9. [Donor cell-derived hematological malignancies after allogeneic hematopoietic stem cell transplantation].
Kato M
Rinsho Ketsueki; 2017; 58(7):813-817. PubMed ID: 28781279
[TBL] [Abstract][Full Text] [Related]
10. Clearance of donor cell leukemia by means of graft versus leukemia effect: A case report.
Ruiz-Delgado GJ; León Peña AA; Gómez-de-León A; Ruiz-Argüelles GJ
Hematology; 2016 Sep; 21(8):470-3. PubMed ID: 26914843
[TBL] [Abstract][Full Text] [Related]
11. Comparable outcomes among unmanipulated haploidentical, matched unrelated, and matched sibling donors in BU-based myeloablative hematopoietic stem cell transplantation for intermediate and adverse risk acute myeloid leukemia in complete remission: a single-center study.
Lu Y; Zhao YL; Zhang JP; Xiong M; Cao XY; Liu DY; Sun RJ; Wei ZJ; Zhou JR; Lu DP
Ann Hematol; 2021 Jun; 100(6):1579-1591. PubMed ID: 33236196
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of CLAE Chemotherapy Regimen Followed by Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed/Refractory Acute Leukemia].
Tao SD; Song LX; Deng Y; Chen Y; Zhang X; Ding BH; Wang CL; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):677-684. PubMed ID: 37356926
[TBL] [Abstract][Full Text] [Related]
13. Mutation of the NPM1 gene contributes to the development of donor cell-derived acute myeloid leukemia after unrelated cord blood transplantation for acute lymphoblastic leukemia.
Rodríguez-Macías G; Martínez-Laperche C; Gayoso J; Noriega V; Serrano D; Balsalobre P; Muñoz-Martínez C; Díez-Martín JL; Buño I
Hum Pathol; 2013 Aug; 44(8):1696-9. PubMed ID: 23465275
[TBL] [Abstract][Full Text] [Related]
14. Donor cell leukemia/myelodysplastic syndrome after allogeneic stem cell transplantation: a rare phenomenon with more challenges for hematologists.
Zhang S; Li L; Cao W; Li Y; Jiang Z; Yu J; Wan D
Hematology; 2021 Dec; 26(1):648-651. PubMed ID: 34474660
[TBL] [Abstract][Full Text] [Related]
15. Second allogeneic hematopoietic stem cell transplantation as treatment for leukemia relapsing following a first transplant.
Blau IW; Basara N; Bischoff M; Günzelmann S; Römer E; Kirsten D; Schmetzer B; Kiehl MG; Fauser AA
Bone Marrow Transplant; 2000 Jan; 25(1):41-5. PubMed ID: 10654013
[TBL] [Abstract][Full Text] [Related]
16. Donor cell leukemia in a patient developing 11 months after an allogeneic bone marrow transplantation for chronic myeloid leukemia.
Ataergin S; Arpaci F; Cetin T; Guran S; Yakicier C; Beyzadeoglu M; Ozet A
Am J Hematol; 2006 May; 81(5):370-3. PubMed ID: 16628734
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.
Gürman G; Arat M; Ilhan O; Konuk N; Beksaç M; Celebi H; Ozcan M; Arslan O; Ustün C; Akan H; Uysal A; Koç H
Cytotherapy; 2001; 3(4):253-60. PubMed ID: 12171713
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive genetic analysis of donor cell derived leukemia with KMT2A rearrangement.
Taniguchi R; Muramatsu H; Okuno Y; Suzuki K; Obu S; Nakatochi M; Shimamura T; Takahashi Y; Horikoshi Y; Watanabe K; Kojima S
Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 28921816
[TBL] [Abstract][Full Text] [Related]
19. [A comparison of the therapeutic effects between related donor and unrelated donor allogeneic hematopoietic stem cell transplantation in treatment of leukemia].
Yang K; Liu QF; Fan ZP; Sun J; Xu D; Wei YQ; Zhang Y; Meng FY
Zhonghua Nei Ke Za Zhi; 2007 Feb; 46(2):135-9. PubMed ID: 17445441
[TBL] [Abstract][Full Text] [Related]
20. Comparison of matched sibling donors versus unrelated donors in allogeneic stem cell transplantation for primary refractory acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT.
Brissot E; Labopin M; Stelljes M; Ehninger G; Schwerdtfeger R; Finke J; Kolb HJ; Ganser A; Schäfer-Eckart K; Zander AR; Bunjes D; Mielke S; Bethge WA; Milpied N; Kalhs P; Blau IW; Kröger N; Vitek A; Gramatzki M; Holler E; Schmid C; Esteve J; Mohty M; Nagler A
J Hematol Oncol; 2017 Jun; 10(1):130. PubMed ID: 28646908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
